Showing results (471-480 of 1,087) with videos related to
Sort By:
Pageof 109
Journal of the American College of Cardiology|September 2, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patientsMattia Galli, Stefano Benenati, Claudio Laudani, et al.Journal of the American College of Cardiology|October 8, 2021
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the WeekAlexander E Sullivan, Michael G Nanna, Tracy Y Wang, et al.International Journal of Cardiology|October 20, 2022
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysisMattia Galli, Stefano Benenati, Andrea Zito, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2009
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trialNobuaki Suzuki, Dominick J Angiolillo, Mark A Tannenbaum, et al.European Heart Journal|July 15, 2025
Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectivesFrancesco Costa, Juan Jose Gomez Doblas, Arancha Díaz Expósito, et al.Journal of the American College of Cardiology|July 15, 2026
Aspirin Withdrawal in Patients With Coronary Artery DiseaseMattia Galli, Davide Capodanno, Jurrien Ten Berg, et al.Thrombosis and Haemostasis|September 7, 2013
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathwaysOscar Ö Braun, Dominick J Angiolillo, Jose L Ferreiro, et al.Cardiovascular Drugs and Therapy|June 19, 2008
Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol designMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.European Heart Journal|February 6, 2016
A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized studyFabiana Rollini, Francesco Franchi, Jung Rae Cho, et al.JACC. Advances|February 4, 2026
Impact of Area-Level Socioeconomic Deprivation on Post-PCI Outcomes Stratified by P2Y12 Inhibitor TherapyJean G Malavé, Cameron D Thomas, Francesco Franchi, et al.Pageof 109